GeoVax Labs, Inc.
USD0.00
-0.00 (-23.91%)
CEO
David Alan Dodd
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.01
52W Low
$0.00
52W High
$0.01
Market Cap
$0.00B
Volume
0.09M
| 10,000 |
| $0.52 |
| 14 Aug 2023 | SPENCER JOHN N JR | director | A-Award | Acquired | 50,000 | $0.76 |
| 14 Aug 2023 | CHASE RANDAL D | director | A-Award | Acquired | 50,000 | $0.76 |
| 14 Aug 2023 | DODD DAVID A | director, officer: President, CEO | A-Award | Acquired | 250,000 | $0.76 |
| 14 Aug 2023 | Kollintzas Dean G | director | A-Award | Acquired | 50,000 | $0.76 |
| 14 Aug 2023 | Reynolds Mark | CFO | A-Award | Acquired | 100,000 | $0.76 |
| 14 Aug 2023 | NEWMAN MARK J | Chief Scientific Officer | A-Award | Acquired | 100,000 | $0.76 |
| 14 Aug 2023 | MCNALLY ROBERT T | director | A-Award | Acquired | 50,000 | $0.76 |
| 25 Apr 2023 | DODD DAVID A | director, officer: President, CEO | P-Purchase | Acquired | 32,000 | $0.64 |